TipRanks
Oncoinvent ASA (DE:7BG)
FRANKFURT:7BG
Germany Market
7BG
Oncoinvent ASA
RESEARCH TOOLSreports

Oncoinvent ASA (7BG) Income Statement

2 Followers

Oncoinvent ASA Income Statement

Last quarter (Q2 2026), Oncoinvent ASA's total revenue was kr8.16M, an increase of 4786.83% from the same quarter last year. In Q2, Oncoinvent ASA's net income was kr-68.07M. See Oncoinvent ASA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 23.04Mkr 848.00Kkr 354.00Kkr 389.00Kkr 774.00K
Gross Profit
kr -64.36Mkr 848.00Kkr 354.00Kkr 389.00Kkr 774.00K
Operating Expenses
kr 77.36Mkr 152.08Mkr 192.17Mkr 306.02Mkr 315.24M
Depreciation and Amortization
kr 11.25Mkr 456.00Kkr 223.00Kkr 883.00Kkr 1.31M
EBITDA
kr -130.47Mkr -134.13Mkr -189.60Mkr -300.92Mkr -308.00M
Operating Income
kr -141.72Mkr -151.23Mkr -191.82Mkr -305.63Mkr -314.46M
Other Income/Expenses
kr -13.35Mkr 11.95Mkr 1.42Mkr 3.51Mkr 5.10M
Pretax Income
kr -155.07Mkr -139.28Mkr -190.40Mkr -302.12Mkr -309.36M
Net Income
kr -155.07Mkr -139.28Mkr -190.40Mkr -302.12Mkr -309.42M
Per Share Metrics
Basic EPS
kr -125.13kr -3.95kr -13.30kr -39.11kr -40.36
Diluted EPS
kr -125.13kr -3.95kr -13.30kr -39.11kr -40.36
Weighted Average Shares Outstanding
 1.24M 35.28M 14.31M 7.73M 7.67M
Weighted Average Shares Outstanding (Diluted)
 1.24M 35.28M 14.31M 7.73M 7.67M
Currency in NOK

Oncoinvent ASA Earnings and Revenue History